Corrigendum to: "Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape".
Aust N Z J Psychiatry May 18, 2026 correction DOI: 10.1177/00048674261450797 (opens in new tab) via PubMed
Summary
AI-generated from the abstractA corrigendum corrects errors in a previously published article about psilocybin's regulatory, ethical, and operational challenges in Australia's clinical landscape. The original article discussed issues surrounding the real-world use of psilocybin, a psychedelic substance, in therapeutic settings. The corrigendum does not present new findings or arguments but amends specific inaccuracies in the original text.
Study at a glance
| Characteristics | Corrigendum |
|---|---|
| Key finding | This is a corrigendum to a previous article on regulatory challenges in Australia; no new findings. |
Abstract
Corrigendum to: "Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape".